Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2022-2025
Title: João Conde: Innovator in TRPV2 Antagonists
Introduction
João Conde is a prominent inventor based in Lisbon, Portugal. He has made significant contributions to the field of molecular medicine, particularly through his innovative work on TRPV2 antagonists. With a total of 2 patents, his research has the potential to impact various medical treatments.
Latest Patents
João Conde's latest patents focus on the discovery of Piperlongumine compounds. These compounds, including Piperlongumine and its analogues, derivatives, and prodrugs, are identified as reversible, allosteric antagonists of the transient receptor potential vanilloid 2 channel (TRPV2). His inventions provide methods for treating conditions characterized by TRPV2 expression using these Piperlongumine compounds.
Career Highlights
Throughout his career, João Conde has worked with esteemed institutions such as the Instituto de Medicina Molecular João Lobo Antunes and the Gulbenkian Institute for Molecular Medicine. His research has been pivotal in advancing the understanding of TRPV2 and its implications in medical treatments.
Collaborations
João has collaborated with notable colleagues, including Tiago Rodrigues and Charlotte Baker. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
João Conde's innovative work in the field of TRPV2 antagonists showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in developing new treatment methods.